HB 688 makes a broad set of changes to Kentucky health care and professional licensing laws, with the largest changes focused on nursing practice and school health emergency response. It revises licensure provisions for registered nurses, licensed practical nurses, and advanced practice registered nurses (APRNs), including provisional licenses, endorsement pathways for out-of-state and foreign-educated nurses, jurisprudence exam requirements, and background-check and reporting rules. The bill also changes APRN prescribing rules by refining collaborative agreement requirements for nonscheduled legend drugs and controlled substances, creating or updating standardized forms and review procedures, and setting out pathways for some APRNs to prescribe without a collaborative agreement after meeting experience and good-standing requirements.
The bill also expands Kentucky’s school medication laws. It authorizes schools to stock and use undesignated glucagon for students experiencing severe hypoglycemia, alongside existing provisions for epinephrine and bronchodilator rescue inhalers/nebulizers. It broadens student self-administration and possession rules to cover medications for diabetes, hypoglycemia, adrenal crisis, and other documented medical conditions, and it adds related training, storage, notification, and liability protections for schools, trained individuals, pharmacists, and health care practitioners. In addition, the bill updates adult protective services registry-query procedures for vulnerable adult service providers and licensing boards.
HB 688 appears to have been received favorably in the House, passing third reading 94-0 on February 26, 2025. No committee transcript was provided, so there is no recorded floor or committee debate in the supplied materials. The unanimous vote suggests broad support, at least in the House, for the bill’s health care workforce and school safety provisions.
The main points of contention embedded in the text are regulatory and scope-of-practice issues, especially around APRN prescribing authority and the conditions under which collaborative agreements are required or can be removed. The bill preserves physician collaboration for many prescribing activities while also creating exemptions after four years of compliant prescribing and good standing, which may reflect a compromise between expanding APRN autonomy and maintaining oversight. Another potential area of concern is the operational burden on schools and providers, including training, stocking, storage, notification, and documentation requirements for glucagon and other emergency medications, though the bill includes liability protections and permissive language to reduce that burden.
HB 688 would amend multiple sections of Kentucky Revised Statutes, primarily in Chapters 314, 209, and 158. It would alter nursing licensure and disciplinary procedures, expand endorsement and temporary practice pathways for nurses, and revise APRN prescribing authority and collaborative agreement requirements. It would also create a new statutory framework for undesignated glucagon in schools and expand school medication/self-administration rules, while adding liability protections for participating schools, practitioners, pharmacists, and trained individuals. The bill would further update adult abuse registry-query procedures for vulnerable adult service providers and licensing boards, affecting hiring and screening practices in long-term care and related settings.
The available voting history indicates strong support for the bill, with the House passing it unanimously 94-0 on third reading. No committee discussion was provided, but the bill’s structure suggests it was designed to balance workforce flexibility, patient access, and safety oversight. Overall, the tone of the legislation is pragmatic and health-care oriented, with multiple provisions aimed at easing licensure pathways and improving emergency preparedness in schools.
The most notable policy tension is in the APRN sections, where the bill both maintains collaborative agreements and creates routes for APRNs to practice more independently after meeting experience and compliance thresholds. That structure suggests differing views on how much autonomy advanced practice nurses should have, especially for prescribing controlled substances. A second area of potential contention is the school health provisions, which expand responsibilities for schools to stock and administer emergency medications and to train staff, even though the bill provides immunity and makes some measures optional or dependent on funding/donations. The adult abuse registry provisions may also raise privacy and due-process concerns because they expand query access while requiring specific procedural safeguards.